Mereo BioPharma Group plc (MREO) Financials
MREO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 40.6 million | 6.6 million |
| Dec. 31, 2025 | 45.9 million | 5.0 million |
| Sept. 30, 2025 | 53.6 million | 7.0 million |
| June 30, 2025 | 62.6 million | 8.5 million |
MREO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -4.3 million | 1.6 million |
| Dec. 31, 2025 | -7.7 million | 1.5 million |
| Sept. 30, 2025 | -7.3 million | 1.7 million |
| June 30, 2025 | -7.7 million | 2.1 million |
MREO Net Income
No data available :(
MREO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 36.2 million | - | - |
| Dec. 31, 2025 | 41.0 million | - | 202000 |
| Sept. 30, 2025 | 48.7 million | - | 397000 |
| June 30, 2025 | 56.1 million | - | 601000 |
MREO Shares Outstanding
MREO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 4.7 million | 4.0 million | - |
| Dec. 31, 2025 | 1521 | 4.2 million | 4.2 million | - |
| Sept. 30, 2025 | - | 3.8 million | 6.0 million | - |
| June 30, 2025 | - | 5.4 million | 5.5 million | - |
MREO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 304488 |
| Dec. 31, 2025 | - | 1000 |
| Sept. 30, 2025 | - | 1000 |
| June 30, 2025 | 500000 | 132000 |
MREO
Price: $0.31
52 week price:
Earnings Per Share: -0.20 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 278100
Market Capitalization: 48.2 million